Explore 3 Stock Ideas & Industry Insights Download Free Report
On 28 September 2026 Renalytix plc (LSE:RENX), a precision medicine diagnostics company focused on kidney disease, announced that its non-executive chair, Julian Baines MBE, intends to step down with effect from 31 December 2026.
IXICO PLC — LSE:IXI closed 4.00% higher on29 September 2026, with the shares at 7.80p after a gain of 0.30p on the day.
Physiomics PLC — LSE:PYC closed 0.76% higher on29 September 2026, with the shares at 0.529p after a gain of 0.004p on the day.
Provexis PLC — LSE:PXS closed 7.11% lower on29 September 2026, with the shares at 0.836p after a decline of 0.064p on the day.
TruSpine Technologies PLC — LSE:TRUE closed 1.11% higher on29 September 2026, with the shares at 3.10p after a gain of 0.03p on the day.
International Biotechnology Trust PLC is a London-listedInvestmenttrust that invests in biotechnology and related companies. Its portfolio managers are Ailsa Craig and Marek Poszepczynski, with Schroder Investment Management Limited acting as alternative investmentFund Managerand company secretary. The trust also holds interests inVenture Capitalfunds managed by …
Hemogenyx (LSE:HEMO), a biopharmaceutical company developing treatments for blood diseases whose shares are listed in the transition category of the Official List, published unaudited half-year results for the six months to 30 June 2026 on 28 September 2026.
TheraCryf (LSE:TCF), an AIM-quoted biotechnology company developing medicines for addiction and neuropsychiatric disorders, published its final results for the year to 31 March 2026 on 28 September 2026.
Coiled Therapeutics plc (LSE:COIL), which is also traded on the US OTCQB market, published interim results for the six months to 30 June 2026 on 28 September 2026.
4basebio PLC (LSE:4BB), the AIM-quoted, Cambridge-based company, published two announcements on 28 September 2026. The first was its unaudited half-year report for the six months ended 30 June 2026. The second set out aPartnershipunder which 4basebio will supply clinical-grade opDNA synthetic DNA starting material …
We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.
These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.
We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.
These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Download Free Report
Hi! How can we help you today?
Loading…